Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA was delisted on the 18th of January, 2023.
13 hedge funds and large institutions have $41.7M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
36% more capital invested
Capital invested by funds: $30.6M → $41.7M (+$11.1M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 13 → 13 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$21.4M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.48M |
| 3 |
DAM
DLD Asset Management
New York
|
+$1.57M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.29M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$489K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.49M |
| 2 |
SCM
Sio Capital Management
New York
|
-$2.37M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$464K |
| 4 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$170K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5K |
AYLA Hedge Fund Activity: Q4 2021 in Review
13 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Ayala Pharmaceuticals, Inc. Common Stock (AYLA) for Q4 2021, worth a combined $41.7M — up 36% from $30.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AYLA positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Harel Insurance Investments & Financial Services, adding an estimated $21.4M. The largest seller was Wellington Management Group, cutting an estimated $2.49M.
- 13 institutional investors held Ayala Pharmaceuticals, Inc. Common Stock (AYLA) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $41.7M of Ayala Pharmaceuticals, Inc. Common Stock stock for Q4 2021, up 36% quarter-over-quarter.
- 5 funds opened new Ayala Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +1 holder.
- The largest Ayala Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was Harel Insurance Investments & Financial Services, an estimated $21.4M added.
- The largest Ayala Pharmaceuticals, Inc. Common Stock seller in Q4 2021 was Wellington Management Group, an estimated $2.49M sold.
Based on aggregated 13F filings for Q4 2021.